Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Pancreatic Cancer Clinical Trials in Philadelphia | 250 Studies

Clinical Trials Pancreatic CancerPhiladelphia

Pancreatic Cancer Clinical Trials in Philadelphia

Find 250 clinical trials for pancreatic cancer near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 250 trials

CompletedStudy of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal AdenocarcinomaThis is a randomized, double blind, 3 arm (1:1:1) study in subjects with 1st-line metastatic pancreatic ductal adenocarcinoma.NCT02289898·Gilbert, Arizona and 41 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

TerminatedPhase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic CancerThe is a double-blind, randomized phase 3 study of 90Y-clivatuzumab tetraxetan with low-dose gemcitabine, versus placebo and low-dose gemcitabine in metastatic pancreatic cancer…NCT01956812·Gilbert, Arizona and 63 others

TerminatedQUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic CancerThis was a Phase 1/2 multi-institution prospective open label study in which subjects with metastatic, locally advanced unresectable or recurrent pancreatic cancer who previously…NCT01834235·San Francisco, California and 11 others

Active not recruitinghuCART-meso + VCN-01 in Pancreatic and Ovarian CancerThis is a single-center phase 1 study to evaluate the safety and feasibility of huCART-meso cells given in combination with VCN-01 in patients with unresectable or metastatic…NCT05057715·Philadelphia, Pennsylvania

CompletedPharmacokinetics of Apixaban in Patients Undergoing PancreaticoduodenectomyStudy investigators will examine the absorption characteristics of apixaban, a direct-acting oral anticoagulation, in patients who have underwent a particular kind of surgery…NCT04191928·Philadelphia, Pennsylvania

CompletedStudy of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic CancerPeople with pancreatic cancer usually have a large amount of the cancer in the area of the pancreas and around it when they are diagnosed with it.NCT00761345·Detroit, Michigan and 2 others

Active not recruitingEfficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsThis trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors and what side effects…NCT03485209·Encinitas, California and 174 others

WithdrawnMRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal AdenocarcinomaThis research study is being conducted to determine the effects of PEGPH20 plus chemotherapy treatment on the MRI characteristics of locally advanced pancreatic cancer patient…NCT04134468·Philadelphia, Pennsylvania

RecruitingAtebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaThe purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.NCT07562152·Huntsville, Alabama and 62 others

Active not recruitingCisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine CarcinomasThis randomized phase II trial studies how well temozolomide and capecitabine work compared to standard treatment with cisplatin or carboplatin and etoposide in treating patients…NCT02595424·Kingman, Arizona and 672 others

UnknownPEN-866 in Patients With Advanced Solid MalignanciesProtocol PEN-866-001 is an open-label, multi-center, first-in-human Phase 1/2a study evaluating PEN-866 in patients with advanced solid malignancies whose disease has progressed…NCT03221400·Springdale, Arkansas and 15 others

CompletedStudy of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic CancerTo compare the efficacy of pegilodecakin in combination with FOLFOX versus FOLFOX alone in participants with metastatic pancreatic cancer as measured by overall survival.NCT02923921·Gilbert, Arizona and 129 others

CompletedEvaluating an Alternative Clinical Genetics Cancer Care Deliver ModelTo evaluate an alternative clinical genetics cancer care delivery model, using non-genetic providers to introduce and order genetic testing.NCT03934606·Philadelphia, Pennsylvania

CompletedA Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010The purpose of this study is to evaluate the safety and tolerability of RO7496353 in combination with a checkpoint inhibitor (CPI) with or without standard-of-care (SOC)…NCT05867121·Los Angeles, California and 26 others

CompletedCombination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic CancerRandomized phase II trial to compare the effectiveness of gemcitabine, paclitaxel, and radiation therapy with or without tipifarnib in treating patients who have locally advanced…NCT00026104·Philadelphia, Pennsylvania

RecruitingEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsThis study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA.NCT04373564·Scottsdale, Arizona and 50 others

Active not recruitingColorectal Cancer Screening in Cystic FibrosisThis multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer…NCT05362344·Los Angeles, California and 25 others

TerminatedPhase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer PatientsThis randomized, Phase 2, open label study aims to assess the efficacy and safety of gemcitabine + nab paclitaxel with or without dociparstat (ODSH) as first line treatment of…NCT01461915·Scottsdale, Arizona and 15 others

CompletedA Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic CancerThis is an open-label Phase 1b dose-escalation study to assess the safety, tolerability, and PK of vantictumab when combined with nab-paclitaxel and gemcitabine.NCT02005315·Los Angeles, California and 4 others

RecruitingZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsThe primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or…NCT06943755·Birmingham, Alabama and 130 others

PreviousPage 11 of 13Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia